Nathalie Griffon

TL;DR: It is shown that BDNF from dopamine neurons is responsible for inducing normal expression of the dopamine D3 receptor in nucleus accumbens both during development and in adulthood, and may be an important determinant of pathophysiological conditions such as drug addiction, schizophrenia or Parkinson's disease.

TL;DR: The occurrence of D3 receptor gene expression in some brain areas receiving low dopamine innervation supports the hypothesis that this receptor may mediate non-synaptic actions of dopamine.

TL;DR: The known behavioural actions of D3 selective agonists support a role for the D3 receptor in motor inhibitions, which should be taken into account for the treatment of motor dysfunctions by dopamine agonists.

TL;DR: Coimmunoprecipitation experiments indicate that D2 and D3 receptors are capable of physical interaction and form complexes with these fragments and that these complexes bind [3H]nemonapride less efficiently or are not correctly targeted to the membrane.

TL;DR: The cloning, pharmacological characterization and expression of the rat fifth melanocortin receptor (MC5) is reported, starting from the dopamine D3 receptor sequence to screen a genomic DNA library.